Tema Oncology ETF Rating $26.79 -0.01 (-0.02%) As of 09:53 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock Tema Oncology ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.CANC Aggregate RatingModerate Buy 2.80Holdings in CANC have an aggregate rating of Moderate Buy based on 329 analyst ratings issued in the past year covering 22 companies (69.5% of the portfolio).CANC Aggregate Price Target$26.800.02% UpsideHigh Prediction$26.80Average Prediction$26.80Low Prediction$26.80Holdings in CANC have an aggregate price target of $26.80 and a range of $26.80 to $26.80 covering 22 companies (69.5% of the portfolio).CANC Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy9 Buy rating(s)Moderate Buy10 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Tema Oncology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 22 CANC Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.88%RHHBYRoche$40.53-0.9%N/A2.5774.74%RVMDRevolution Medicines$38.83+2.1%4.3371 of 5 stars3.00$69.92 80.1%13News CoveragePositive News4.68%BBIOBridgeBio Pharma$50.02+0.9%4.237 of 5 stars3.00$61.35 22.7%174.58%MRUSMerus$67.77+0.7%2.318 of 5 stars3.08$88.75 31.0%12News CoveragePositive NewsAnalyst Forecast4.45%LLYEli Lilly and Company$737.71+0.5%4.9993 of 5 stars2.67$950.17 28.8%24Trending NewsAnalyst Upgrade3.81%GMABGenmab A/S$25.20+1.7%3.5947 of 5 stars2.64$37.60 49.2%11News Coverage3.80%SMMTSummit Therapeutics$25.44+2.5%2.2465 of 5 stars2.63$33.31 30.9%16Positive NewsAnalyst ForecastGap Down3.36%NUVLNuvalent$75.97-0.2%3.4396 of 5 stars3.08$118.91 56.5%12News CoveragePositive News3.29%ZLABZai Lab$31.92-2.0%2.2908 of 5 stars2.86$56.35 76.6%7Analyst Forecast3.26%ACLXArcellx$69.98+0.1%2.1192 of 5 stars3.13$114.31 63.3%15News CoveragePositive News3.25%EXELExelixis$38.13-1.0%4.882 of 5 stars2.52$44.06 15.5%23Positive NewsAnalyst Downgrade3.14%ONCBeOne Medicines$296.10-1.3%1.4279 of 5 stars3.00$330.89 11.7%73.14%BMYBristol Myers Squibb$47.39-0.5%4.7491 of 5 stars2.24$56.38 19.0%21Positive News2.99%LEGNLegend Biotech$34.710.0%3.8986 of 5 stars2.91$74.22 113.8%11Positive NewsAnalyst Forecast2.92%AMGNAmgen$286.82-0.4%4.7533 of 5 stars2.33$304.43 6.1%21Positive NewsAnalyst Forecast2.71%ABBVAbbVie$207.40-0.3%4.7103 of 5 stars2.96$214.95 3.6%27Analyst Forecast2.29%IDYAIDEAYA Biosciences$25.17+0.7%4.4482 of 5 stars2.75$47.10 87.1%12News Coverage2.13%MRKMerck & Co., Inc.$83.65-0.5%4.997 of 5 stars2.35$107.44 28.4%20Positive News1.64%IMNMImmunome$10.07+1.2%1.5805 of 5 stars3.00$22.50 123.4%8Analyst Forecast1.62%JANXJanux Therapeutics$23.45+0.4%2.5479 of 5 stars3.08$86.90 270.6%13News CoveragePositive News1.44%COGTCogent Biosciences$12.43+0.4%3.5275 of 5 stars2.82$19.00 52.9%11News CoveragePositive NewsAnalyst Forecast1.40%ARGXargenex$700.62-1.0%3.0878 of 5 stars3.10$763.47 9.0%21Trending NewsAnalyst ForecastAnalyst Revision This page (NASDAQ:CANC) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredSmall Washington, DC Group Could Crash US StocksNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredTrump's "Big Beautiful Bill" hides ugly truthWashington’s new “Big Beautiful Bill” promises tax breaks… but the fine print tells a different story: trillio...Defi Master | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Oncology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Oncology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access